Use of eltrombopag for the treatment of thrombocytopenia in hypoplastic myelodysplastic syndrome.
作者信息
Gauchan Dron, Shaaban Hamid, Gedeon David, Maroules Michael
机构信息
Department of Hematology/Oncology, St Joseph's Regional Medical Center, Seton Hall University School of Health and Medical Sciences, Paterson, NJ, USA.
出版信息
Ann Hematol. 2014 Oct;93(10):1777-8. doi: 10.1007/s00277-014-2032-1. Epub 2014 Feb 20.
PMID:24554304
Abstract
摘要
相似文献
1
Use of eltrombopag for the treatment of thrombocytopenia in hypoplastic myelodysplastic syndrome.
Ann Hematol. 2014 Oct;93(10):1777-8. doi: 10.1007/s00277-014-2032-1. Epub 2014 Feb 20.
2
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial.
Lancet Haematol. 2017 Mar;4(3):e127-e136. doi: 10.1016/S2352-3026(17)30012-1. Epub 2017 Feb 3.
3
Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial.
Lancet Haematol. 2015 Oct;2(10):e417-26. doi: 10.1016/S2352-3026(15)00149-0. Epub 2015 Oct 1.
4
Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial.
Lancet Haematol. 2018 Jan;5(1):e34-e43. doi: 10.1016/S2352-3026(17)30228-4. Epub 2017 Dec 11.
5
Successful platelet count recovery in lupus-associated thrombocytopenia with the thrombopoietin agonist eltrombopag.
Clin Rheumatol. 2014 Sep;33(9):1347-9. doi: 10.1007/s10067-014-2600-8. Epub 2014 Apr 17.
6
Eltrombopag for treatment of thrombocytopenia-associated disorders.
Expert Opin Pharmacother. 2015;16(14):2243-56. doi: 10.1517/14656566.2015.1085512.
7
Eltrombopag in thrombocytopenia.
N Engl J Med. 2008 Mar 6;358(10):1072; author reply 1072-3. doi: 10.1056/NEJMc073571.
8
Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.
N Engl J Med. 2012 Nov 22;367(21):2056. doi: 10.1056/NEJMc1211471.
9
Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.
N Engl J Med. 2012 Nov 22;367(21):2055-6. doi: 10.1056/NEJMc1211471.
10
Successful treatment of severe thrombocytopenia with the use of thrombopoeitin receptor agonist eltrombopag in a patient with chronic myelomonocytic leukemia.
J Oncol Pharm Pract. 2015 Feb;21(1):74-5. doi: 10.1177/1078155214544076. Epub 2014 Jul 24.
Zotero 插件